Global IVD & LDT For Autoimmune Diseases Market by Technology (Clinical Chemistry, Coagulation, Hematology), Application (Addison's Disease, Alopecia Areata, Ankylosing Spondylitis) - Forecast 2024-2030- Product Image

Sale

Global IVD & LDT For Autoimmune Diseases Market by Technology (Clinical Chemistry, Coagulation, Hematology), Application (Addison's Disease, Alopecia Areata, Ankylosing Spondylitis) - Forecast 2024-2030

Report
199 Pages
March 2024
Region: Global
360iResearch™
ID: 5674356

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The IVD & LDT For Autoimmune Diseases Market size was estimated at USD 17.27 billion in 2023, USD 18.30 billion in 2024, and is expected to grow at a CAGR of 5.22% to reach USD 24.68 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the IVD & LDT For Autoimmune Diseases Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the IVD & LDT For Autoimmune Diseases Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the IVD & LDT For Autoimmune Diseases Market, highlighting leading vendors and their innovative profiles. These include Adaptive Biotechnologies Corporation, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., bioMerieux, Inc., Corgenix, Inc., Creative Biolabs Inc., Diasorin S.P.A., in.vent Diagnostica GmbH, Johnson & Johnson Services, Inc., Microbix Biosystems Inc., PerkinElmer, Inc., Roche Diagnostics Corporation, SQI Diagnostics Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the IVD & LDT For Autoimmune Diseases Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
- Clinical Chemistry
- Coagulation
- Hematology
- Immunoassays
- Microbiology
- Molecular Diagnostics
Application
- Addison’s Disease
- Alopecia Areata
- Ankylosing Spondylitis
- Antiphospholipid Antibody Syndrome
- Crohn’s Disease
- Diabetes Type 1
- Multiple Sclerosis
- Narcolepsy
- Psoriasis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Ulcerative Colitis
- Uveitis

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the IVD & LDT For Autoimmune Diseases Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the IVD & LDT For Autoimmune Diseases Market?
What are the technology trends and regulatory frameworks in the IVD & LDT For Autoimmune Diseases Market?
What is the market share of the leading vendors in the IVD & LDT For Autoimmune Diseases Market?
Which modes and strategic moves are suitable for entering the IVD & LDT For Autoimmune Diseases Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. IVD & LDT For Autoimmune Diseases Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of autoimmune disorders in economies
5.1.1.2. Increasing awareness regarding diagnostic tests for autoimmune diseases
5.1.1.3. Rising development of healthcare infrastructure and growing healthcare expenditure
5.1.2. Restraints
5.1.2.1. Concerns regarding extra-neuropsychiatric health problems
5.1.3. Opportunities
5.1.3.1. Technological advancements in the field of IVD
5.1.3.2. Rising collaborative growth for the development of in-vitro diagnostic (IVD) test kits
5.1.4. Challenges
5.1.4.1. Stringent regulations of IVDs & LDTs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. IVD & LDT For Autoimmune Diseases Market, by Technology

6.1. Introduction
6.2. Clinical Chemistry
6.3. Coagulation
6.4. Hematology
6.5. Immunoassays
6.6. Microbiology
6.7. Molecular Diagnostics

7. IVD & LDT For Autoimmune Diseases Market, by Application

7.1. Introduction
7.2. Addison’s Disease
7.3. Alopecia Areata
7.4. Ankylosing Spondylitis
7.5. Antiphospholipid Antibody Syndrome
7.6. Crohn’s Disease
7.7. Diabetes Type 1
7.8. Multiple Sclerosis
7.9. Narcolepsy
7.10. Psoriasis
7.11. Rheumatoid Arthritis
7.12. Systemic Lupus Erythematosus
7.13. Systemic Sclerosis
7.14. Ulcerative Colitis
7.15. Uveitis

8. Americas IVD & LDT For Autoimmune Diseases Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific IVD & LDT For Autoimmune Diseases Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa IVD & LDT For Autoimmune Diseases Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Adaptive Biotechnologies Corporation
12.1.2. Agilent Technologies Inc.
12.1.3. Bio-Rad Laboratories, Inc.
12.1.4. bioMerieux, Inc.
12.1.5. Corgenix, Inc.
12.1.6. Creative Biolabs Inc.
12.1.7. Diasorin S.P.A.
12.1.8. in.vent Diagnostica GmbH
12.1.9. Johnson & Johnson Services, Inc.
12.1.10. Microbix Biosystems Inc.
12.1.11. PerkinElmer, Inc.
12.1.12. Roche Diagnostics Corporation
12.1.13. SQI Diagnostics Inc.
12.1.14. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET RESEARCH PROCESS
FIGURE 2. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, 2023 VS 2030
FIGURE 3. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET DYNAMICS
FIGURE 7. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COAGULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY ADDISON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY ANTIPHOSPHOLIPID ANTIBODY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY CROHN’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY DIABETES TYPE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY SYSTEMIC SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY UVEITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. CANADA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. MEXICO IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. MEXICO IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CHINA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. INDIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. INDIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. JAPAN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. JAPAN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. PHILIPPINES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. SINGAPORE IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. SINGAPORE IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. SOUTH KOREA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. SOUTH KOREA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. TAIWAN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. TAIWAN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. THAILAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. THAILAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. VIETNAM IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. VIETNAM IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. DENMARK IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. DENMARK IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. EGYPT IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. EGYPT IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. FINLAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. FINLAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. FRANCE IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. FRANCE IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. GERMANY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. GERMANY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ISRAEL IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. ISRAEL IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. ITALY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. ITALY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. NETHERLANDS IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. NETHERLANDS IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. NIGERIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. NIGERIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. NORWAY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. NORWAY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. POLAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. POLAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. QATAR IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. QATAR IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. SAUDI ARABIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. SOUTH AFRICA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. SOUTH AFRICA IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. SPAIN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. SPAIN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. SWEDEN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. SWEDEN IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. SWITZERLAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. SWITZERLAND IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. TURKEY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. TURKEY IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 114. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 115. IVD & LDT FOR AUTOIMMUNE DISEASES MARKET LICENSE & PRICING

Companies Mentioned

Adaptive Biotechnologies Corporation
Agilent Technologies Inc.
Bio-Rad Laboratories, Inc.
bioMerieux, Inc.
Corgenix, Inc.
Creative Biolabs Inc.
Diasorin S.P.A.
in.vent Diagnostica GmbH
Johnson & Johnson Services, Inc.
Microbix Biosystems Inc.
PerkinElmer, Inc.
Roche Diagnostics Corporation
SQI Diagnostics Inc.
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 18.3 Billion
Forecasted Market Value ( USD ) by 2030	$ 24.68 Billion
Compound Annual Growth Rate	5.2%
Regions Covered	Global
No. of Companies Mentioned	14

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global IVD & LDT For Autoimmune Diseases Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Animal Autoimmune Diseases Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Global In-Vitro Diagnostics Market by Component (Data Management Software, Instruments, Reagents & Kits), Technology (Clinical Chemistry, Coagulation & Hemostasis, Hematology), Application, End User - Forecast 2024-2030

Global IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Forecast to 2028

Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User - Global Forecast to 2030